Xeris Biopharma Holdings (XERS) Free Cash Flow (2020 - 2025)
Historic Free Cash Flow for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to $18.4 million.
- Xeris Biopharma Holdings' Free Cash Flow rose 32193.86% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 13353.34%. This contributed to the annual value of -$37.0 million for FY2024, which is 2135.55% up from last year.
- Per Xeris Biopharma Holdings' latest filing, its Free Cash Flow stood at $18.4 million for Q3 2025, which was up 32193.86% from $182000.0 recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Free Cash Flow registered a high of $18.4 million during Q3 2025, and its lowest value of -$48.4 million during Q1 2022.
- In the last 5 years, Xeris Biopharma Holdings' Free Cash Flow had a median value of -$16.1 million in 2022 and averaged -$14.4 million.
- Per our database at Business Quant, Xeris Biopharma Holdings' Free Cash Flow plummeted by 16209.66% in 2021 and then surged by 32193.86% in 2025.
- Over the past 5 years, Xeris Biopharma Holdings' Free Cash Flow (Quarter) stood at -$29.1 million in 2021, then soared by 44.56% to -$16.1 million in 2022, then surged by 146.35% to $7.5 million in 2023, then crashed by 73.56% to $2.0 million in 2024, then soared by 833.27% to $18.4 million in 2025.
- Its Free Cash Flow stands at $18.4 million for Q3 2025, versus $182000.0 for Q2 2025 and -$10.0 million for Q1 2025.